Real-World Treatment Study of Soliris (Eculizumab)
NCT06448715
Observational
Goyang-si, South Korea
View Trial DetailsNCT Number: NCT00745966
The purpose of this study is to reassure the clinical study data on atypical antipsychotics effect on quality of life in Korean Bipolar patients.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Research Site, Kyunggi-do, Choonchun-si, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
AstraZeneca
Industry
A 8-Week, Multicenter, Open-Label, Observational Study of Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder
Acronym: POLE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06448715
Observational
Goyang-si, South Korea
View Trial DetailsNCT06614062
Observational
Chengdu, Sichuan, China
View Trial DetailsNCT06433154
Arthroscopic Surgery, Follow-Up Studies
Lund, Sweden
View Trial DetailsNCT03138772
Observational
Toronto, Ontario, Canada
View Trial Details